Long non-coding RNA (lncRNA), which is a kind of noncoding RNA, is generally characterized as being more than 200 nucleotide transcripts in length. LncRNAs exhibit many biological activities, ...including, but not limited to, cancer development. In this review, a search of the PubMed database was performed to identify relevant studies published in English. The term "lncRNA or long non-coding RNA" was combined with a range of search terms related to the core focus of the review: mechanism, structure, regulation, and cancer. The eligibility of the retrieved studies was mainly based on the abstract. The decision as to whether or not the study was included in this review was made after a careful assessment of its content. The reference lists were also checked to identify any other study that could be relevant to this review. We first summarized the molecular mechanisms of lncRNAs in tumorigenesis, including competing endogenous RNA (ceRNA) mechanisms, epigenetic regulation, decoy and scaffold mechanisms, mRNA and protein stability regulation, transcriptional and translational regulation, miRNA processing regulation, and the architectural role of lncRNAs, which will help a broad audience better understand how lncRNAs work in cancer. Second, we introduced recent studies to elucidate the structure of lncRNAs, as there is a link between lncRNA structure and function and visualizing the architectural domains of lncRNAs is vital to understanding their function. Third, we explored emerging evidence for regulators of lncRNA expression, lncRNA turnover, and lncRNA modifications (including 5-methylcytidine, N6-methyladenosine, and adenosine to inosine editing), highlighting the dynamics of lncRNAs. Finally, we used autophagy in cancer as an example to interpret the diverse mechanisms of lncRNAs and introduced clinical trials of lncRNA-based cancer therapies.
Over the past few decades, RNA sequencing has significantly progressed, becoming a paramount approach for transcriptome profiling. The revolution from bulk RNA sequencing to single-molecular, ...single-cell and spatial transcriptome approaches has enabled increasingly accurate, individual cell resolution incorporated with spatial information. Cancer, a major malignant and heterogeneous lethal disease, remains an enormous challenge in medical research and clinical treatment. As a vital tool, RNA sequencing has been utilized in many aspects of cancer research and therapy, including biomarker discovery and characterization of cancer heterogeneity and evolution, drug resistance, cancer immune microenvironment and immunotherapy, cancer neoantigens and so on. In this review, the latest studies on RNA sequencing technology and their applications in cancer are summarized, and future challenges and opportunities for RNA sequencing technology in cancer applications are discussed.
The roles of long non-coding RNAs in cancer metabolism remain largely unexplored. Here we identify FILNC1 (FoxO-induced long non-coding RNA 1) as an energy stress-induced long non-coding RNA by FoxO ...transcription factors. FILNC1 deficiency in renal cancer cells alleviates energy stress-induced apoptosis and markedly promotes renal tumor development. We show that FILNC1 deficiency leads to enhanced glucose uptake and lactate production through upregulation of c-Myc. Upon energy stress, FILNC1 interacts with AUF1, a c-Myc mRNA-binding protein, and sequesters AUF1 from binding c-Myc mRNA, leading to downregulation of c-Myc protein. FILNC1 is specifically expressed in kidney, and is downregulated in renal cell carcinoma; also, its low expression correlates with poor clinical outcomes in renal cell carcinoma. Together, our study not only identifies FILNC1 as a negative regulator of renal cancer with potential clinical value, but also reveals a regulatory mechanism by long non-coding RNAs to control energy metabolism and tumor development.FoxO are commonly down-regulated transcription factors and tumor suppressors in renal cell cancer (RCC). Here, the authors show that upon energy stress FoxOs induce the expression of the long non-coding RNA FILNC1, which inhibits survival of RCC by downregulating c-Myc and c-Myc-dependent metabolic rewiring.
The roles and regulatory mechanisms of ferroptosis (a non-apoptotic form of cell death) in cancer remain unclear. The tumour suppressor BRCA1-associated protein 1 (BAP1) encodes a nuclear ...deubiquitinating enzyme to reduce histone 2A ubiquitination (H2Aub) on chromatin. Here, integrated transcriptomic, epigenomic and cancer genomic analyses link BAP1 to metabolism-related biological processes, and identify cystine transporter SLC7A11 as a key BAP1 target gene in human cancers. Functional studies reveal that BAP1 decreases H2Aub occupancy on the SLC7A11 promoter and represses SLC7A11 expression in a deubiquitinating-dependent manner, and that BAP1 inhibits cystine uptake by repressing SLC7A11 expression, leading to elevated lipid peroxidation and ferroptosis. Furthermore, we show that BAP1 inhibits tumour development partly through SLC7A11 and ferroptosis, and that cancer-associated BAP1 mutants lose their abilities to repress SLC7A11 and to promote ferroptosis. Together, our results uncover a previously unappreciated epigenetic mechanism coupling ferroptosis to tumour suppression.
Cancer stem cells (CSCs) are cancer‐initiating cells that are not only a source of tumorigenesis but also the cause of tumour progression, metastasis and therapy resistance. EBV‐associated gastric ...cancer (EBVaGC) is a distinct subtype of gastric cancer with unique clinicopathological and molecular features. However, whether CSCs exist in EBVaGC, and the tumorigenic mechanism of EBV, remains unclear. Here, NOD/SCID mice were injected subcutaneously with the EBVaGC cell line SNU719 and treated with 5‐fluorouracil weekly. Successive generations of xenografts yielded a highly malignant EBVaGC cell line, SNU‐4th, which displays properties of CSCs and mainly consists of CD44+CD24− cells. In SNU‐4th cells, an EBV‐encoded circRNA, ebv‐circLMP2A, expression increased and plays crucial roles in inducing and maintaining stemness phenotypes through targeting miR‐3908/TRIM59/p53 axis. Additionally, high expression of ebv‐circLMP2A is significantly associated with metastasis and poor prognosis in patients with EBVaGC. These findings not only provide evidence for the existence of CSCs in EBVaGC and elucidate the pathogenic mechanism of ebv‐circLMP2A in EBVaGC, but also provide a promising therapeutic target for EBVaGC.
Synopsis
The circRNA LMP2A produced by the Epstein‐Barr virus induces stemness of EBV‐associated gastric cancer cells by attenuating the tumor suppressive effect of the miR‐3908/TRIM59/p53 axis, thereby promoting metastasis and tumor progression.
Cells with properties of cancer stem cells were isolated form EBV‐associated gastric cancer (EBVaGC).
The levels of an EBV‐encoded circRNA (ebv‐circLMP2A) are significantly increased in EBVaGC.
ebv‐circLMP2A has crucial roles in inducing and maintaining cancer stemness in EBVaGC.
High expression of ebv‐circLMP2A is significantly associated with metastasis and poor prognosis in EBVaGC patients.
The circRNA LMP2A produced by the Epstein‐Barr virus induces stemness of EBV‐associated gastric cancer cells by attenuating the tumor suppressive effect of the miR‐3908/TRIM59/p53 axis, thereby promoting metastasis and tumor progression.
Background
In pancreatic cancer, methods to predict early recurrence (ER) and identify patients at increased risk of relapse are urgently required.
Purpose
To develop a radiomic nomogram based on MR ...radiomics to stratify patients preoperatively and potentially improve clinical practice.
Study Type
Retrospective.
Population
We enrolled 303 patients from two medical centers. Patients with a disease‐free survival ≤12 months were assigned as the ER group (n = 130). Patients from the first medical center were divided into a training cohort (n = 123) and an internal validation cohort (n = 54). Patients from the second medical center were used as the external independent validation cohort (n = 126).
Field Strength/Sequence
3.0T axial T1‐weighted (T1‐w), T2‐weighted (T2‐w), contrast‐enhanced T1‐weighted (CET1‐w).
Assessment
ER was confirmed via imaging studies as MRI or CT. Risk factors, including clinical stage, CA19‐9, and radiomic‐related features of ER were assessed. In addition, to determine the intra‐ and interobserver reproducibility of radiomic features extraction, the intra‐ and interclass correlation coefficients (ICC) were calculated.
Statistical Tests
The area under the receiver‐operator characteristic (ROC) curve (AUC) was used to evaluate the predictive accuracy of the radiomic signature in both the training and test groups. The results of decision curve analysis (DCA) indicated that the radiomic nomogram achieved the most net benefit.
Results
The AUC values of ER evaluation for the radiomics signature were 0.80 (training cohort), 0.81 (internal validation cohort), and 0.78 (external validation cohort). Multivariate logistic analysis identified the radiomic signature, CA19‐9 level, and clinical stage as independent parameters of ER. A radiomic nomogram was then developed incorporating the CA19‐9 level and clinical stage. The AUC values for ER risk evaluation using the radiomic nomogram were 0.87 (training cohort), 0.88 (internal validation cohort), and 0.85 (external validation cohort).
Data Conclusion
The radiomic nomogram can effectively evaluate ER risks in patients with resectable pancreatic cancer preoperatively, which could potentially improve treatment strategies and facilitate personalized therapy in pancreatic cancer.
Level of Evidence: 4
Technical Efficacy: Stage 4
J. Magn. Reson. Imaging 2020;52:231–245.
A highly efficient and easily tunable luminescence is significant for solid-state luminescent (SSL) materials. However, achieving a photoluminescence quantum yield (PLQY) close to unity and tuning ...the emission remain challenging tasks. Metal doping strategies enable resolution of these issues. Herein, we report the preparation of a novel organic-inorganic lead-free indium-based metal halide hybrid (MP)3InCl6•EtOH (MP = C4H10ON) with a typical zero-dimension structure. When excited at 320 nm, (MP)3InCl6•EtOH exhibits a dual emission band at 420 and 600 nm, which originates from the organic cation MP and the InCl63- octahedral unit. The photoluminescence can be significantly enhanced through Sb3+ doping, resulting in an increase in PLQY from 0.78% to near unity. Multiple emission color tunings have been achieved by regulating the Sb doping level and the radiation wavelength, resulting in a change in emission color from blue → white → orange. Optical characterizations reveal that the significantly enhanced emission centered at 600 nm can be attributed to more efficient absorption, closely associated with an additional 1S0 → 3P1 transition in the inorganic octahedron In(Sb)Cl63- due to Sb3+ doping. With its excellent optical performance, a white light emitting diode (WLED) has been successfully fabricated by coating the mixture of (MP)3InCl6•EtOH:15%Sb3+ with blue phosphor BaMgAl10O17:Eu2+ onto a UV LED chip. The WLED device exhibits perfect white light emission with regard to the International Commission on Illumination (CIE) coordinates of (0.36, 0.34). Significantly, the WLED device maintains a stable correlated color temperature (CCT) range of 4119-4393 K and CIE coordinates (x: 0.37-0.34, y: 0.35-0.33) as the driven current varies from 20 to 200 mA, demonstrating outstanding stability across different power levels. This work not only presents a novel system for achieving remarkably enhanced luminescent performance and tuning emission bands in 0D metal halides but also represents a significant step toward achieving resistance to color drifting for stable WLEDs.
Long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cellular processes. However, the potential involvement of lncRNAs in kinase signalling remains largely unknown. ...AMP-activated protein kinase (AMPK) acts as a critical sensor of cellular energy status. Here we show that the lncRNA NBR2 (neighbour of BRCA1 gene 2) is induced by the LKB1-AMPK pathway under energy stress. On energy stress, NBR2 in turn interacts with AMPK and promotes AMPK kinase activity, thus forming a feed-forward loop to potentiate AMPK activation during energy stress. Depletion of NBR2 attenuates energy-stress-induced AMPK activation, resulting in unchecked cell cycling, altered apoptosis/autophagy response, and increased tumour development in vivo. NBR2 is downregulated and its low expression correlates with poor clinical outcomes in some human cancers. Together, the results of our study uncover a mechanism coupling lncRNAs with metabolic stress response, and provides a broad framework to understand further the regulation of kinase signalling by lncRNAs.
This study considers the boundary stabilization for stochastic delayed Cohen-Grossberg neural networks (SDCGNNs) with diffusion terms by the Lyapunov functional method. In the realization of NNs, ...sometimes time delays and diffusion phenomenon cannot be ignored, so Cohen-Grossberg NNs with time delays and diffusion terms are studied in this article. Moreover, different from the previously distributed control, the boundary control is used to stabilize the system, which can reduce the spatial cost of the controller and is easy to implement. Boundary controllers are presented for system with Neumann boundary and mixed boundary conditions, and criteria are derived such that the controlled system achieves mean-square exponential stabilization. Based on the criterion, the effects of diffusion matrix, coupling strength, coupling matrix, and time delays on exponentially stability are analyzed. In the process of analysis, two difficulties need to be addressed: 1) how to introduce boundary control into system analysis? and 2) how to analyze the influence of system parameters on stability? We deal with these problems by using Poincaré's inequality and Schur's complement lemma. Moreover, mean-square exponential synchronization of stochastic delayed Hopfield NNs with diffusion terms, as an application of the theoretical result, is considered under the boundary control. Examples are given to illustrate the effectiveness of the theoretical results.